Short Interest in CV Sciences, Inc. (OTCMKTS:CVSI) Decreases By 82.5%

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 6,400 shares, a decrease of 82.5% from the December 31st total of 36,600 shares. Based on an average daily volume of 697,100 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Trading Up 1.3 %

CVSI traded up $0.00 on Tuesday, hitting $0.04. 15,268 shares of the stock traded hands, compared to its average volume of 261,604. The business has a fifty day moving average price of $0.04 and a two-hundred day moving average price of $0.04. CV Sciences has a 52 week low of $0.03 and a 52 week high of $0.10. The firm has a market capitalization of $7.48 million, a PE ratio of -4.05 and a beta of 0.66.

CV Sciences Company Profile

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.